Navigation Links
XTENT to Present CUSTOM I and CUSTOM II Trial Data at TCT 2007
Date:10/16/2007

of Cardiology at the HELIOS Heart

Center in Siebgurg, Germany and principal investigator of the CUSTOM I and

II clinical trials, will review the results to date from Biolimus A9(R)

DES clinical trials and registries. Professor Grube will present two-year

results from the CUSTOM I clinical trial and one-year results from the

CUSTOM II clinical trial.

Bernard de Bruyne, M.D. Ph.D, Cardiovascular Center, OLV Hospital in

Aalst, Belgium, will provide an overview of the Custom NX technology in a

presentation titled "XTENT Custom NX DES Systems: A Novel Approach to the

Percutaneous Treatment of Coronary Artery Disease (CAD)."

Time/Location: 8:00-10:00 p.m. EDT; Renaissance Washington, D.C. Hotel,

Grand Ballroom, 999 Ninth Street NW

Monday, October 22

Event: Analyst Webcast and Teleconference on CUSTOM I and CUSTOM II Data

XTENT will host a webcast and teleconference call to review the CUSTOM I

and CUSTOM II data presented on Sunday. The teleconference and slide

presentation can be accessed via the investor relations section of the

company's website at http://investor.xtentinc.com/events.cfm or by calling

888-663-2258 (from the U.S.), 913-312-1277 (international). Please dial in

or access the website five to ten minutes prior to the beginning of the

call. The webcast will be archived on the website for a minimum of three

months, and can be accessed at the investor relations portion of the

company's website at http://investor.xtentinc.com

Time/Location: 7:00 a.m. EDT

About XTENT

XTENT, Inc. is a medical device company focused on developing and commercializing innovative customizable drug eluting stent (DES) systems for the treatment of coronary artery disease (CAD). CAD is the most common form of
'/>"/>

SOURCE XTENT, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. XTENT Announces Promising Six-Month Custom II Trial Data Presented at EuroPCR Meeting
2. The Past, Present and Future of HLA Typing
3. Sygnis Pharma AG announces date for presentation of clinical results
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
7. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
8. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
9. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
10. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... NEW YORK , July 30, 2015 ... releases a new research report with market ... size, share, forecast, porter analysis, recent developments, ... Global Industry Insight: Biosensors Market ...      (Logo: http://photos.prnewswire.com/prnh/20150727/756778 ) ...
(Date:7/30/2015)... AUSTIN, Texas , July 30, 2015 ... solutions company focused on gynecologic disease, announced ... 2015 financial results after the market close ... an investor conference call and webcast at ... August 13, 2015 at 4:30pm Eastern/1:30pm Pacific  ...
(Date:7/30/2015)... 30, 2015 What can be ... areas are going to grow at the fastest rates? ... revenues to 2025, assessing data, trends, opportunities and prospects ... 176 tables, charts, and graphs. Discover the most lucrative ... Our new study lets you assess forecasted sales at ...
Breaking Medicine Technology:Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 4Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 6
(Date:7/31/2015)... , ... July 31, 2015 , ... Physical therapy for knee osteoarthritis ... patient's quality of life. It keeps the patient from doing what they want or need ... have a hard time using the stairs. The patient's exercise regime may be limited by ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... 100% organic, natural, therapeutic-grade oils from ingredients sourced all over the world, then ... “With considerable effort, we have developed the highest-quality oils in the industry, which ...
(Date:7/31/2015)... ... ... “ Crack’em ” was featured on NewsWatch as part of its monthly ... Forstrom, a technology expert and special reporter for NewsWatch, conducted the review and shared ... can be a very messy experience, especially when cracking eggs. Cracking an egg is ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... wide variety of nutritional and wellness products, announced the addition of Vincent Aquilino ... massage therapy, active isolated stretching and the prevention and rehabilitation of injuries, has ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... care client base, with the recent implementation of Microsoft Dynamics GP for a ... the industry, Intellitec is now supporting senior living communities in 16 states. This ...
Breaking Medicine News(10 mins):Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 2Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 3Health News:Living Pure Essential Oils takes Therepeutic Essential Oil Market by Storm 2Health News:Make Less Mess while Cooking with Crack’em 2Health News:NPI Welcomes Vincent Aquilino to Board of Directors 2Health News:Intellitec Solutions Expands Long term Care ERP Offerings to Maine 2
... MONDAY, Aug. 16 (HealthDay News) -- A new study finds that ... lower than what their wife or female partner makes, while women ... their husband or male partner. The findings suggest that disparities ... the young couples they studied. "With women, they were less ...
... We all want that summer glow that comes from a day ... implications for our health. Now Dr. Niva Shapira of Tel Aviv ... in the sun safer ― and it,s all in our food. ... Dr. Shapira has shown that a diet rich in antioxidants and ...
... 2010 Young adults who abuse amphetamines may be at ... leading from the heart, UT Southwestern Medical Center researchers have ... of American Heart Journal , researchers examined medical records ... old hospitalized from 1995 to 2007 and found that amphetamine ...
... assesses donor characteristics impacting liver transplantation outcomes, does not bear ... is suggested from large-scale, national data. Rather, hepatitis ... to poor graft survival in transplant patients, according to a ... were to confirm the effect of the Donor Risk Index ...
... implications for developing treatments against cancer and potentially deadly ... the function of proteins that can enhance the progression ... published in the journal Genes and Development . ... professor of cell biology, and Christopher Hellen, DPhil, associate ...
... researchers found that terminology and efforts to frame an ... have no effect on public opinion concerning the ongoing ... Using an experimental approach involving a nationally representative sample, ... not rhetoric, such as the use of ,same-sex couple, ...
Cached Medicine News:Health News:Infidelity Rises When She Makes More Than He Does 2Health News:Infidelity Rises When She Makes More Than He Does 3Health News:SPF on your plate 2Health News:SPF on your plate 3Health News:Amphetamine use increases risk of aortic tears in young adults, UT Southwestern researchers report 2Health News:Henry Ford Hospital study: Donor Risk Index does not impact outcomes on a small scale 2Health News:Researchers find function of proteins that can enhance the progression of viruses and cancer cells 2Health News:Rhetoric, framing efforts have little influence in same-sex marriage debate 2
... DrDrugs®: Drug Guide ... with over 760 Integrated ... most comprehensive, up-to-date and ... built in drug dosing ...
Clinician's Pocket Drug Reference 2005 includes key elements of commonly used medications that are essential information for both the student and practicing physician....
... of the authoritative 2005 edition ... Code of Federal Regulations (CFR) ... published in the Federal Register. ... released by the Government Printing ...
... The Quality Module QS I evaluates ... of centrifuged serum samples. The System ... and recognizes if a sample contains ... with the Aliquoting System RSD 800A ...
Medicine Products: